Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor

W Martin, RF Furchgott, GM Villani and D Jothianandan

Removal of endothelial cells on rings of rat aorta increased the sensitivity to the selective alpha-1 adrenoceptor agonist phenylephrine, to the nonselective alpha adrenoceptor agonist norepinephrine and to the selective alpha-2 adrenoceptor agonist clonidine. In the case of the first two, which are strong agonists for the alpha-1 adrenoceptor-mediating contraction, removal of endothelium increased sensitivity 4- and 6-fold at the EC30 level, but produced little or no increase in maximum. In the case of clonidine, a partial agonist for the alpha-1 adrenoceptor, which gave only about 15% of the maximum given by phenylephrine on endothelium-containing rings, removal of the endothelium not only shifted the curve to the left but also increased the maximum to about 50% of that given by phenylephrine. The depression of sensitivity to these agonists in rings with endothelium appeared to be due to the vasodepressor action of endothelium-derived relaxing factor (EDRF), as hemoglobin, a specific blocking agent of EDRF, abolished this depression. It is unlikely that the endothelium- dependent depression was due to stimulation of release of EDRF, because clonidine did not produce endothelium-dependent relaxation in precontracted rings even when its contractile action was blocked by the alpha-1 adrenoceptor antagonist prazosin. Further evidence against alpha adrenoceptor agents stimulating release of EDRF was that neither phenylephrine nor clonidine induced a rise in cyclic GMP in aortic rings, whereas acetylcholine, which does release EDRF, caused a large rise in cyclic GMP content. The possibility that the muscle cells of intact rat aortic rings were under the tonic influence of released EDRF was supported by the finding that, in the absence of any contractile agent, hemoglobin induced a fall in the basal level of cyclic GMP in endothelium-containing rings. Also consistent with EDRF being released spontaneously was the finding that contraction induced by 5- hydroxytryptamine, like that by alpha-adrenergic agonists, was also depressed in endothelium-containing rings of aorta. When the efficacy of phenylephrine as an alpha-1 agonist was reduced to about the initial efficacy of clonidine by irreversible inactivation of a very large fraction of alpha-1 adrenoceptors of the smooth muscle cells by pretreatment with dibenamine, the concentration-contraction curves for phenylephrine for both endothelium-containing rings and for endothelium- denuded rings now became very similar to the corresponding curves obtained for clonidine before receptor inactivation.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 237, Issue 2, pp. 529-538, 05/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				N. Ulu, H. Buikema, W. H. v. Gilst, and G. Navis Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1854 - 1860. [Abstract] [Full Text] [PDF]

				P W F Hadoke, R S Lindsay, J R Seckl, B R Walker, and C J Kenyon Altered vascular contractility in adult female rats with hypertension programmed by prenatal glucocorticoid exposure. J. Endocrinol., March 1, 2006; 188(3): 435 - 442. [Abstract] [Full Text] [PDF]

				O. S. Possas, A. K. Johnson, and S. J. Lewis Role of nitrosyl factors in the hindlimb vasodilation elicited by baroreceptor afferent nerve stimulation Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R741 - R748. [Abstract] [Full Text] [PDF]

				A. A Voors, P. P. van Geel, H. Buikema, M. Oosterga, D. J van Veldhuisen, and W. H van Gilst High Angiotensin II Responsiveness is Associated with Decreased Endothelium-Dependent Relaxation in Human Arteries Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 145 - 150. [Abstract] [PDF]

				J. A. S. Barreto-Filho, F. M. Consolim-Colombo, G. M. Guerra-Riccio, R. D. Santos, A. P. Chacra, H. F. Lopes, S. H. Teixeira, T. Martinez, J. E. Krieger, and E. M. Krieger Hypercholesterolemia Blunts Forearm Vasorelaxation and Enhances the Pressor Response During Acute Systemic Hypoxia Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1660 - 1666. [Abstract] [Full Text] [PDF]

				N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF]

				M. Ohtsuka, F. Konno, H. Honda, T. Oikawa, M. Ishikawa, N. Iwase, K. Isomae, F. Ishii, H. Hemmi, and S. Sato PPA250 [3-(2,4-Difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl) Phenoxy]ethoxy}-2-phenylpyridine], a Novel Orally Effective Inhibitor of the Dimerization of Inducible Nitric-Oxide Synthase, Exhibits an Anti-Inflammatory Effect in Animal Models of Chronic Arthritis J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 52 - 57. [Abstract] [Full Text] [PDF]

				K. Ruijtenbeek, C. G. A. Kessels, E. Villamor, C. E. Blanco, and J. G. R. De Mey Direct effects of acute hypoxia on the reactivity of peripheral arteries of the chicken embryo Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R331 - R338. [Abstract] [Full Text] [PDF]

				D. Sun, A. Huang, F. A. Recchia, Y. Cui, E. J. Messina, A. Koller, and G. Kaley Nitric oxide-mediated arteriolar dilation after endothelial deformation Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H714 - H721. [Abstract] [Full Text] [PDF]

				K. M Smith, J. B Macmillan, K. M McCulloch, and J. C McGrath NOS inhibition potentiates norepinephrine but not sympathetic nerve-mediated co-transmission in resistance arteries Cardiovasc Res, August 15, 1999; 43(3): 762 - 771. [Abstract] [Full Text] [PDF]

				I. Fleming, J. Bauersachs, A. Schafer, D. Scholz, J. Aldershvile, and R. Busse Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase PNAS, February 2, 1999; 96(3): 1123 - 1128. [Abstract] [Full Text] [PDF]

				N. Sennequier, D. Wolan, and D. J. Stuehr Antifungal Imidazoles Block Assembly of Inducible NO Synthase into an Active Dimer J. Biol. Chem., January 8, 1999; 274(2): 930 - 938. [Abstract] [Full Text] [PDF]

				G. D. Thomas, M. Sander, K. S. Lau, P. L. Huang, J. T. Stull, and R. G. Victor Impaired metabolic modulation of alpha -adrenergic vasoconstriction in dystrophin-deficient skeletal muscle PNAS, December 8, 1998; 95(25): 15090 - 15095. [Abstract] [Full Text] [PDF]

				M. P. Massett, S. J. Lewis, and K. C. Kregel Effect of heating on the hemodynamic responses to vasoactive agents Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R844 - R853. [Abstract] [Full Text] [PDF]

				G.-W. He and C.-Q. Yang Basal or Stimulated Release?: Evidence of EDRF (NO) Release by TP-Receptor Agonist U46619 Vascular and Endovascular Surgery, July 1, 1997; 31(4): 433 - 439. [Abstract] [PDF]

				V. M. Campese, M. Tawadrous, R. Bigazzi, S. Bianchi, A. S. Mann, S. Oparil, and L. Raij Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension Hypertension, September 1, 1996; 28(3): 335 - 340. [Abstract] [Full Text]

				R. L. Davisson, R. A. Shaffer, A. K. Johnson, and S. J. Lewis Use-Dependent Loss of Active Sympathetic Neurogenic Vasodilation After Nitric Oxide Synthase Inhibition in Conscious Rats: Evidence for the Presence of Preformed Stores of Nitric Oxide–Containing Factors Hypertension, September 1, 1996; 28(3): 347 - 353. [Abstract] [Full Text]

				R. M. White, C. O. Rivera, and C. B. Davison Differential Contribution of Endothelial Function to Vascular Reactivity in Conduit and Resistance Arteries From Deoxycorticosterone-Salt Hypertensive Rats Hypertension, June 1, 1996; 27(6): 1245 - 1253. [Abstract] [Full Text]

				K. S.K. Chang, M. Z. Zhong, and R. F. Davis Indigo Carmine Inhibits Endothelium-Dependent and -Independent Vasodilation Hypertension, February 1, 1996; 27(2): 228 - 234. [Abstract] [Full Text]

				G. Berkenboom, D. Brekine, P. Unger, K. Grosfils, M. Staroukine, and J. Fontaine Chronic Angiotensin-Converting Enzyme Inhibition and Endothelial Function of Rat Aorta Hypertension, November 1, 1995; 26(5): 738 - 743. [Abstract] [Full Text]

				S. J. Razzuk and T. M. Zellers Balloon Dilatation of Porcine Pulmonary Arteries Decreases Endothelium-Dependent Relaxations and Increases Vasoconstriction to Aggregating Platelets Circulation, February 15, 1995; 91(4): 1221 - 1228. [Abstract] [Full Text]

				G.-W. He and C.-Q. Yang "Vasoactivators"--a New Concept for Naturally Secreted vasoconstrictor Substances Angiology, April 1, 1994; 45(4): 265 - 271. [Abstract] [PDF]